The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of prostate-specific antigen (PSA) decline among the Latin American subgroup of LIBERTAS: A phase 3 study of apalutamide (APA) plus continuous versus intermittent androgen deprivation therapy (ADT) in metastatic castration-sensitive prostate cancer (mCSPC).
 
Andrea Gomes
Consulting or Advisory Role - Adium Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Janssen Oncology
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb/Pfizer; Janssen Oncology; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology
 
Alejandro Lara
Consulting or Advisory Role - Ipsen; MSD Oncology
Speakers' Bureau - Bayer; MSD; MSD Oncology; Takeda
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen; MSD Oncology; Roche; Roche
 
Daniel Preto
No Relationships to Disclose
 
Suelen Martins
No Relationships to Disclose
 
Jesus David Calvo Dominguez
Honoraria - Johnson & Johnson; Roche
 
Pedro Domingues
Consulting or Advisory Role - Bayer; Johnson & Johnson/Janssen; Novartis
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Sanofi; Johnson & Johnson/Janssen; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Adium Pharma
 
Juan Pablo Feregrino
Honoraria - Ipsen; Johnson & Johnson; Merck; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Ipsen; Johnson & Johnson; Merck; Merck Sharp & Dohme; Roche
Speakers' Bureau - Ipsen; Johnson & Johnson; Merck; Merck Sharp & Dohme; Roche
 
Jose Mauricio Mota
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Merck; Novartis; Pfizer; Zodiac Pharma
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen Oncology; Merck; Novartis; Pfizer; Zodiac Pharma
Research Funding - Bayer
Expert Testimony - Adium Pharma; Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Janssen Oncology; Zodiac Pharma
 
Rodrigo Pacheco
Speakers' Bureau - Roche
Research Funding - Janssen
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Livia Andrade
Consulting or Advisory Role - Adium Pharma; Janssen-Cilag; Novartis
Speakers' Bureau - Adium Pharma; Daiichi Sankyo/Astra Zeneca; Ipsen; Janssen-Cilag
Research Funding - Bayer; Janssen-Cilag; Regeneron; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Bayer Schering Pharma; Johnson & Johnson/Janssen
 
Lucas Nogueira
Consulting or Advisory Role - Bayer
Speakers' Bureau - Astellas Pharma; Bayer
 
Alex Dos Santos
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Sukie Shopeju
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Amitabha Bhaumik
Employment - Abbvie (I); Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Abbvie (I); Johnson & Johnson/Janssen
 
Suneel Dinkar Mundle
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Sharon McCarthy
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson and Johnson
 
Sara Rosas
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Mark Wildgust
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Arun Azad
Honoraria - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Consulting or Advisory Role - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Novartis
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hinova Pharmaceuticals (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono; Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Hinova Pharmaceuticals; Janssen; Merck Serono; Pfizer; Sanofi; Tolmar
 
Neeraj Agarwal
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exelixis; Pfizer